MedPath
NMPA Approval

Sofosbuvir, Velpatasvir and Voxilaprevir tablets

国药准字HJ20190061

November 12, 2024

H20190061

Drug Information

索磷维伏片

沃士韦

片剂

每片含400mg索磷布韦、100mg维帕他韦和100mg伏西瑞韦

化学药品

November 12, 2024

November 11, 2029

Company Information

Applicant Company

Carrigtohill, County Cork, T45 DP77, Ireland

Manufacturing Company

IDA Business and Technology Park, Carrigtohill, Co. Cork, Ireland

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

索磷维伏片 - NMPA 批准文号 | MedPath